Table 1 Clinical and biological characteristics of subjects of five groups
From: The liver steatosis severity and lipid characteristics in primary biliary cholangitis
|  | PBC (n = 108) | Normal (n = 92) | CHC (n = 92) | CHB (n = 94) | NAFLD (n = 93) | P value |
|---|---|---|---|---|---|---|
Male gender | 8 (7.4%) | 8 (8.7%) | 8 (8.7%) | 8 (8.5%) | 7 (7.5%) | 0.995 |
Age (years) | 52 (27–69) | 52 (26–68) | 52 (27–70) | 51 (28–68) | 52 (27–69) | 0.989 |
BMI (kg/m2) | 24.0 (18.0–30.0) | 24.0 (17.0–30.0) | 24.0 (19.0–30.0) | 25.0 (18.0–30.0) | 26.0 (18.0–30.0) | 0.041 |
CAP (dB/m) | 205.5 ± 34.7 | 221.1 ± 34.6 | 243.0 ± 35.7 | 228.0 ± 32.6 | 290.4 ± 39.1 | < 0.001**** |
ALT (IU/L) | 36.1 (8.0–920.0) | 17.5 (3.0–40.0) | 20.5 (5.0–1134.0) | 23.5 (6.0–929.0) | 52.0 (9.0–739.0) | < 0.001**** |
AST (IU/L) | 46.5 (16.0–845.0) | 20.0 (10.0–34.0) | 24.5 (11.0–514.0) | 23.0 (10.0–464.0) | 52.0 (15.0–268.0) | < 0.001**** |
TBil (IU/L) | 17.4 (6.7–443.0) | 12.5 (6.4–21.0) | 15.1 (6.8–109.5) | 14.7 (5.9–146.0) | 12.9 (6.4–193.5) | < 0.001**** |
DBil (IU/L) | 5.1 (0.8–193.0) | 4.2 (1.9–8.4) | 5.1 (1.8–47.8) | 4.4 (0.6–112.9) | 4.0 (1.0–134.3) | 0.002*** |
ALP (IU/L) | 142.0 (26.0–1100.0) | 71.5 (30.0–189.0) | 76.5 (40.0–196.0) | 70.0 (37.0–201.0) | 87.0 (41.0–206.0) | < 0.001**** |
GGT (IU/L) | 120.0 (9.0–1429.0) | 17.0 (8.0–68.0) | 20.0 (8.0–286.0) | 19.5 (8.0–517.0) | 52.5 (10.0–835.0) | < 0.001**** |
TBA (IU/L) | 15.3 (1.3–408.8) | 2.6 (0.6–28.7) | 3.9 (0.8–73.9) | 4.7 (0.8–182.3) | 5.4 (1.0–71.3) | < 0.001**** |
TC (IU/L) | 5.0 (1.0–14.0) | 4.5 (2.9–5.2) | 4.3 (1.0–7.0) | 4.6 (2.5–7.7) | 5.1 (2.0–7.0) | < 0.001**** |
TG (IU/L) | 1.2 (0.5–7.4) | 1.1 (0.5–1.7) | 1.0 (0.4–4.4) | 1.0 (0.4–6.8) | 1.9 (0.6–15.1) | < 0.001**** |
HDL-C (IU/L) | 1.5 (0.2–6.2) | 1.3 (0.7–2.7) | 1.3 (0.5–2.9) | 1.4 (0.2–6.1) | 1.2 (0.3–5.7) | < 0.001**** |
LDL-C (IU/L) | 2.6 (0.8–6.2) | 2.7 (1.0–3.9) | 2.6 (0.6–5.3) | 2.8 (1.1–5.9) | 3.2 (0.8–5.5) | < 0.001**** |